Metagenomics, powered by Next-Generation Sequencing (NGS), is transforming how we detect, analyze, and understand microorganisms in both clinical and environmental settings. Unlike traditional methods that focus on specific organisms, metagenomic analysis sequences all genetic material in a sample—providing an unbiased, high-resolution snapshot of entire microbial communities.
This advanced technology is revolutionizing human diagnostics by enabling rapid, comprehensive identification of pathogens, including emerging or hard-to-culture organisms. It is also redefining environmental biosafety, supporting hygiene monitoring in high-risk spaces such as hospitals, transportation hubs, and public facilities.
At DNA Sequence Laboratory, an ISO 17025-certified facility (Certificate No. 1379 by ESYD), we offer cutting-edge metagenomic solutions to improve both human health and environmental biosecurity. From clinical diagnostics to surface hygiene analysis, our services help clients meet regulatory standards, enhance safety protocols, and promote public health.
At DNA Sequence Laboratory, we specialize in next-generation diagnostics using Next-Generation Sequencing (NGS) technology to accurately detect and analyze pathogens in clinical samples such as saliva and mucus.
As an ISO 17025-certified laboratory (Certificate No. 1379 by ESYD), we provide high-resolution, unbiased pathogen identification, antimicrobial resistance (AMR) gene detection, and functional microbial profiling—empowering healthcare providers with deeper, more actionable insights.
Why NGS in Human Diagnostics?
- Comprehensive Pathogen Detection: NGS allows for the simultaneous detection of a wide range of pathogens—including rare, emerging, or hard-to-culture organisms. Unlike traditional culture-based methods, it delivers unbiased, culture-independent results that are crucial in accurately diagnosing complex infections, especially in the respiratory system.
- Ideal for identifying infections when conventional methods fall short.
- Antimicrobial Resistance (AMR) and Functional Insights: Our NGS platform goes beyond identification:
- Detects antimicrobial resistance genes, help clinicians make informed, targeted treatment decisions
- Supports antibiotic stewardship programs and AMR surveillance
- Provides functional profiling of microbial communities to understand their role in disease progression and treatment response
Applications in Clinical Settings
- Respiratory infections (e.g., pneumonia, bronchitis)
- Complex or persistent infections with unknown etiology
- Hospital-acquired infections
- Public health outbreak tracking
Partner with DNA Sequence Laboratory
Experience the future of clinical diagnostics. Our NGS-based metagenomic solutions offer unparalleled precision and depth, helping clinicians deliver faster, more accurate diagnoses, implement targeted therapies, and improve patient outcomes.
→ Contact us to learn more about integrating metagenomics into your diagnostic protocols.
